News
Trastuzumab biosimilar is equivalent on central review
CHICAGO – In a 20-country neoadjuvant trial, findings when tissue was centrally reviewed differed somewhat from those when tissue was reviewed...
News
Youth with rhabdomyosarcoma see better survival with maintenance chemo
CHICAGO – These findings mark the first major advance for this rare cancer in 30 years and have led to a new standard of care in Europe.
News
New cell-free DNA assays hold promise for lung cancer screening
CHICAGO – Three blood-based assays for circulating cell-free DNA detected lung cancer of stage I-IIIA had sensitivities of 38%-51% and...
News
H&N cancer may be undertreated in women
CHICAGO – Female patients with H&N cancer had almost twice the ratio of cancer deaths to noncancer deaths.
News
TAILORx marks major advance for precision medicine in breast cancer
CHICAGO – Practice-changing data show that most women with HR-positive, HER2-negative, early-stage breast cancer who have an intermediate...
Video
Maintenance chemo boosts survival for youth with high-risk rhabdomyosarcoma
CHICAGO - Lead study author Dr. Gianni Bisogno discusses the practice changing results and describes plans for a new trial to explore alternate...
Video
TAILORx: Most women with intermediate risk ER+ breast cancer can safely skip chemo
CHICAGO - Lead study author Dr. Joseph A. Sparano discusses the implications of the new data for decision-making and future plans for the tumor...
News
Atezolizumab has PFS benefit in first-line squamous NSCLC
CHICAGO – Atezolizumab prolongs PFS by about a month, and patients derived benefit regardless of the level of PD-L1 expression.
Video
A blood test to detect lung cancer inches toward the clinic
CHICAGO - Dr. Geoffrey R. Oxnard discusses interim results from the Circulating Cell-Free Genome Atlas project and ongoing work to bring the blood...
Video
Metastatic colorectal cancer chemo costs double in Washington vs. British Columbia
CHICAGO - Dr. Todd Yezefski discusses the drivers of cost disparities and implications for policy makers.
Video
Head and neck cancers: Women less commonly receive intensive chemo
CHICAGO - Senior study author Dr. Jed A. Katzel discusses ongoing research to understand the reasons behind the apparent disparities.
News
CBT-I bests acupuncture for treating insomnia among cancer survivors
In a randomized trial, both CBT-I and acupuncture reduced insomnia severity among cancer survivors, but the former had the edge.
News
Uptake of lung cancer screening is exceedingly low
The annual rate of LDCT screening for lung cancer among eligible current and former heavy smokers was just 1.9% in 2016 across the United States...
News
New remote monitoring system lessens symptoms in head and neck cancer
The CYCORE system, which harnesses wireless sensor and mobile technology to remotely monitor vitals and symptoms, reduces symptom severity in...
News
Adjuvant trastuzumab for breast cancer: 6 months may suffice
Disease-free survival was similarly high whether women received adjuvant trastuzumab for the current standard of 12 months or for just 6 months....
